I don't necessarily agree with this. Have a look at the share price run up from iil and pbt prior to the release of their respective phase 2 trials. These were also highly binary events. Even more recently for bot prior to acne results and paradigm right now. I really expect ftt to do something not dissimilar, however obviously hopefully with a different trial outcome than iil and pbt....(!?!) I do agree that hopefully the company will be in the process of getting the story out there (with some updated analyst reports containing valuations and / or interview / roadshows (recorded and put on YouTube). For me there is a strong investment case here and it deserves to be broadcast a bit more now the recruitment is complete.
FTT Price at posting:
5.7¢ Sentiment: Buy Disclosure: Held
